Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Cancer Center Support Grant
Yee, D., Antonarakis, E., Beckman, K. B., Betts, B., Blaes, A. H., Eaton, A., Ellis, K. M., Felices, M., Geller, M. A., Ghebre, R. G., Griffin, T. J., Hallstrom, T. C., Harki, D. A., Hatsukami, D. K., Hirsch, B. A., Huang, R. S. S., Johnson, S., Juckett, M. B., Lange, C. A., Le, C. T., Luo, X., McKenna, D. H., Miller, J. S., Moriarity, B. S., Muretta, J. M., Murray, T., Nelson, H. H., Ondrey, F. G., Patel, M. R., Pennell, C. A., Petersen, A. J., Peterson, L. A., Poynter, J., Pratt, R. J., Sarver, A. L., Schendzielos, D. L., Schilz, A., Schwertfeger, K., Seelig, D., Shimizu, Y., Stepanov, I., Temiz, N. A., Ventz, S., Villalta, P. W., Vogel, R., Wagner, J. E., Wang, J., Webber, B. R., Weigel, B. J., Yamamoto, M. & Zhang, L.
NIH NATIONAL CANCER INSTITUTE (NCI)
2/1/24 → 1/31/29
Project: Research project
-
-
-
Increasing access to cancer trials in Minnesota (InACT-MN)
Erickson, B. K., Geller, M. A., Greeno, E. W., Kratzke, R. A., Ondrey, F. G., Teoh, D. G. & Yee, D.
NIH NATIONAL CANCER INSTITUTE (NCI)
9/18/23 → 8/31/28
Project: Research project
-
-
Association of antibiotic exposure with residual cancer burden in HER2-negative early stage breast cancer
ISPY2 consortium, Dec 2024, In: npj Breast Cancer. 10, 1, 24.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial
I-SPY 2 Trial Consortium, Apr 2024, In: Breast Cancer Research and Treatment. 204, 3, p. 589-597 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Insulin promotes growth in breast cancer cells through the type I IGF receptor in insulin receptor deficient cells
Monteiro, M., Zhang, X. & Yee, D., Jan 1 2024, In: Experimental Cell Research. 434, 1, 113862.Research output: Contribution to journal › Article › peer-review
Open Access -
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery
Albain, K. S., Yau, C., Petricoin, E. F., Wolf, D. M., Lang, J. E., Chien, A. J., Haddad, T., Forero-Torres, A., Wallace, A. M., Kaplan, H., Pusztai, L., Euhus, D., Nanda, R., Elias, A. D., Clark, A. S., Godellas, C., Boughey, J. C., Isaacs, C., Tripathy, D., Lu, J., & 29 others , Feb 15 2024, In: Clinical Cancer Research. 30, 4, p. 729-740 12 p.Research output: Contribution to journal › Article › peer-review
-
An open label phase II study of safety and clinical activity of naltrexone for treatment of hormone refractory metastatic breast cancer
Vijayakumar, J., Haddad, T., Gupta, K., Sauers, J. & Yee, D., Feb 2023, In: Investigational New Drugs. 41, 1, p. 70-75 6 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations
Press/Media
-
Talking with the experts: October is National Breast Cancer Awareness Month
10/2/20
1 item of Media coverage
Press/Media: Expert Comment
-
Breast cancer screenings during the pandemic
9/28/20
1 item of Media coverage
Press/Media: Expert Comment
-
Regis, Great Clips want to be industry leaders in reopening process
5/4/20
1 item of Media coverage
Press/Media: Expert Comment